Theodora Katsila

Research Associate Professor - Head of Lab

National Hellenic Research Foundation

Athens, Greece

2 profile visits

Biochemist. Consultant. Interpreneur. Eager to co-create data-driven solutions, test disruptive ideas and scale them into real-world health impact.

My organisation

National Hellenic Research Foundation

Research Institution

Athens, Greece

The National Hellenic Research Foundation was founded in 1958. It is a non-profit Research Foundation supervised by the General Secretariat for Research and Innovation (GSRI) of the Ministry of Development & Investments in Greece. NHRF consists of the following Institutes and Units: Institute of Historical Research (IHR). The IHR conducts research on the political, economic, social and cultural history of the Greek areas and the regions where Hellenism has been active, from prehistoric antiquity to the modern era. Institute of Biology, Medicinal Chemistry and Biotechnology (IBMCB). IBMCB acts as a focal point, unique within Greece, for innovation at the interface of Chemistry and Biology through a modern interdisciplinary approach to the solution of state-of-the-art issues in the areas of health, drug research and biotechnology. Institute of Theoretical and Physical Chemistry (TPCI). TPCI advances research in selected fields of experimental and computational/theoretical chemistry and physics, with emphasis on nanomaterials with advanced functionality for energy conversion and storage, photonics, and electrochemical applications.

About me

Biochemist. Consultant. Entrepreneur

Dr. Theodora Katsila is a Research Associate Professor and Group Leader at the Institute of Chemical Biology, National Hellenic Research Foundation (NHRF), where she leads the Biomarker Discovery & Translational Research Lab. Leveraging the IN3 “tri-modal innovation engine” framework, integrating in silico, in vitro, and in vivo approaches, her team repurposes drugs, advanced materials, and smart systems, leveraging proteoforms to highlight digital and molecular translational biomarkers. The lab focuses on extracellular vesicles/ particles as they serve as both translational biomarkers and functional tools in bioengineering and biocompatibility assessment. Dr. Katsila’s work has produced pioneering computational and experimental pipelines, all aimed at accelerating TRLs. She is a prolific author, editor, and speaker; a recipient of corporate grants; an award-winning scientist; and a co-inventor. She received the 2023 Rosalind Franklin Society Special Award in Science and was highlighted as Humans of HUPO (2023). Dr Katsila serves as a G2MC steering committee member and co-leads the G2MC FHH flagship project.

Social media

Skills

Biomarker Discovery & Translational Research
drug repurposing
Smart Health Systems
Advanced Materials
EVs
Multiomics

Interests

Data-Driven Health Solutions
Disruptive Innovation in Healthcare
Digital Health & eHealth Transformation

Marketplace (1)

Project cooperation
IN3
IN3 is a tri-modal innovation engine that fuses in silico, in vitro, and in vivo approaches into a single framework
- HEALTH
- CANCER
- Project Phase
- Laboratory Tested
- Prototype Available
- Expertise - Partner seeks Consortium/Coordinator
- HORIZON-HLTH-2024-DISEASE-12-01: European partnership for pandemic preparedness
- HORIZON-MISS-2024-CANCER-01-05: Improving the understanding and management of late-effects in adolescents and young adults (AYA) with cancer
- HORIZON-HLTH-2024-CARE-14-01: Pre-commercial procurement for environmentally sustainable, climate neutral and circular health and care systems
- HORIZON-MISS-2023-CANCER-01-04: Establish best practices and tools to improve the quality of life for childhood cancer patients, survivors and their families in European regions
- HORIZON-HLTH-2024-DISEASE-13-01: Implementation research for management of multiple long-term conditions in the context of non-communicable diseases (Global Alliance for Chronic Diseases - GACD)
- HORIZON-MISS-2023-CANCER-01-01: Addressing poorly-understood tumour-host interactions to enhance immune system-centred treatment and care interventions in childhood, adolescent, adult and elderly cancer patients
Author
Theodora Katsila
Research Associate Professor - Head of Lab at National Hellenic Research Foundation
Athens, Greece